https://www.indianpharmapost.com/lilly-to-buy-ventyx-biosciences-for-12-billion-187982026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/briefs-medicamen-biotech-and-gland-pharma-188132026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/icmr-panacea-biotec-complete-enrollment-for-indias-first-indigenous-dengue-vaccine-phase-3-study-188122026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/ascletis-pharma-gets-fda-nod-for-phase-ii-diabetes-trial-of-oral-glp-1-drug-188112026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/arrowhead-pharmaceuticals-gets-green-light-for-first-of-its-kind-fcs-therapy-188102026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/stereotaxis-scores-fda-nod-for-groundbreaking-magic-robotic-heart-catheter-188092026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/takeda-protagonist-submit-fda-application-for-groundbreaking-polycythemia-vera-therapy-188082026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/bayers-sevabertinib-gets-green-light-from-fda-and-china-for-advanced-lung-cancer-188072026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/rapid-acting-adhd-treatment-azstarys-now-approved-in-china-188062026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/alzheimers-could-soon-be-detected-with-a-simple-finger-prick-188052026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/acesion-pharma-launches-phase-2-trial-for-groundbreaking-atrial-fibrillation-therapy-188042026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/alumis-reports-breakthrough-phase-3-results-for-oral-psoriasis-therapy-188032026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/cellenkos-scores-fda-orphan-drug-designation-for-ck0804-in-rare-blood-cancer-188022026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/gsks-exdensur-wins-japanese-nod-for-severe-asthma-188012026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/biocon-biologics-to-introduce-three-new-oncology-biosimilars-eyes-75-billion-market-opportunity-188002026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/amgen-snaps-up-uk-biotech-dark-blue-therapeutics-in-up-to-840m-oncology-deal-187992026-01-08T00:00:00+05:30always0.9https://www.indianpharmapost.com/wockhardt-files-marketing-authorisation-application-for-wck-5222-with-ema-188142026-01-08T00:00:00+05:30always0.9